Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
846.1 INR | -2.85% | -0.46% | +30.32% |
May. 10 | Market Heavyweights Lifts Indian Equities to End Week Higher | MT |
May. 10 | Strides Pharma Arm Gets US FDA's Approval for Generic Drug for Hypocalcemia | MT |
Business Summary
Number of employees: 2,850
Sales per Business
INR in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Pharmaceutical
100.0
%
| 30,703 | 100.0 % | 36,884 | 100.0 % | +20.13% |
Sales per region
INR in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
North America
52.2
%
| 12,059 | 39.3 % | 19,261 | 52.2 % | +59.73% |
Europe
22.7
%
| 6,769 | 22.0 % | 8,370 | 22.7 % | +23.66% |
Africa
12.2
%
| 5,707 | 18.6 % | 4,506 | 12.2 % | -21.05% |
Australia
8.4
%
| 3,175 | 10.3 % | 3,116 | 8.4 % | -1.86% |
Global
2.2
%
| 482 | 1.6 % | 807 | 2.2 % | +67.49% |
Asia (excluding India)
1.2
%
| 1,971 | 6.4 % | 461 | 1.2 % | -76.63% |
India
0.6
%
| 473 | 1.5 % | 219 | 0.6 % | -53.82% |
Others
0.4
%
| 67 | 0.2 % | 144 | 0.4 % | +115.54% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Arun N. Kumar
CEO | Chief Executive Officer | 63 | 90-06-27 |
Badree Komandur
DFI | Director of Finance/CFO | - | 10-01-31 |
Compliance Officer | - | 17-02-02 | |
Corporate Officer/Principal | - | 22-09-30 | |
Amit Gupta
AUD | Comptroller/Controller/Auditor | - | - |
Rj Ramesh
TRE | Treasurer | - | - |
Sormistha Ghosh
LAW | General Counsel | - | - |
Corporate Officer/Principal | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Arun N. Kumar
CEO | Chief Executive Officer | 63 | 90-06-27 |
Director/Board Member | 80 | 17-05-17 | |
Director/Board Member | 64 | 12-07-26 | |
Director/Board Member | 77 | 14-07-24 | |
Director/Board Member | 62 | Jan. 31 | |
Badree Komandur
DFI | Director of Finance/CFO | - | 10-01-31 |
Director/Board Member | 56 | 19-12-10 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 91,909,714 | 62,766,717 ( 68.29 %) | 0 | 68.29 % |
Company contact information
Strides Pharma Science Ltd.
Strides House Bannerghatta Road
560076, Bangalore
+91 80 6784 0000
http://www.strides.comGroup companies
Name | Category and Sector |
---|---|
Arco Lab Pvt Ltd.
Arco Lab Pvt Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Strides Pharma Science Ltd., Arco Lab Pvt Ltd. is a company based in Bengaluru, India. |
Miscellaneous Commercial Services
|
Strides Pharma, Inc.
Strides Pharma, Inc. Pharmaceuticals: MajorHealth Technology Strides Pharma, Inc. manufactures and distributes pharmaceutical products. The firm operates through the following brand name: JointFlex, Pedia Care, and NiteThru. The company is headquartered in Lambertville, NJ. |
Pharmaceuticals: Major
|
Strides Pharma Global Pte Ltd.
Strides Pharma Global Pte Ltd. Pharmaceuticals: MajorHealth Technology Strides Pharma Global Pte Ltd. manufactures and distributes pharmaceutical products. The company was founded in 2013 and is headquartered in Singapore. |
Pharmaceuticals: Major
|
Strides Pharma UK Ltd.
Strides Pharma UK Ltd. Medical DistributorsDistribution Services Strides Pharma UK Ltd. engages in the acquisition, development, marketing and distribution of a wide range of generic medicines and other over the counter products. It provides anti emetic, histamine, infective spasticity medicines, cardiovascular, dental, dermatology, diuretics, nasal, lubricants, and steroids medicines. The company was founded in 1993 and is headquartered in Watford, the United Kingdom. |
Medical Distributors
|
Vivimed Life Sciences Pvt Ltd.
Vivimed Life Sciences Pvt Ltd. Pharmaceuticals: MajorHealth Technology Vivimed Life Sciences Pvt Ltd. provides pharmaceutical services. The joint venture company is based in Hyderabad, India and was founded in 2017. |
Pharmaceuticals: Major
|
Sector
Sales per Business
Sales per region
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+32.41% | 961M | |
+21.60% | 44.12B | |
+22.22% | 22.61B | |
+18.22% | 15.11B | |
+13.78% | 13.61B | |
+61.05% | 13.34B | |
-8.98% | 6.94B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+15.65% | 5.75B |
- Stock Market
- Equities
- STAR Stock
- Company Strides Pharma Science Limited